Form 8-K - Current report:
SEC Accession No. 0001140361-24-048133
Filing Date
2024-12-02
Accepted
2024-12-02 09:05:18
Documents
15
Period of Report
2024-12-02
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20039392_8k.htm   iXBRL 8-K 57435
2 EXHIBIT 3.1 ef20039392_ex3-1.htm EX-3.1 15073
3 EXHIBIT 3.2 ef20039392_ex3-2.htm EX-3.2 54623
  Complete submission text file 0001140361-24-048133.txt   294614

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lbph-20241202.xsd EX-101.SCH 4004
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lbph-20241202_lab.xml EX-101.LAB 23416
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lbph-20241202_pre.xml EX-101.PRE 17075
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20039392_8k_htm.xml XML 4558
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

EIN.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 241517542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)